Compare KFY & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KFY | TWST |
|---|---|---|
| Founded | 1969 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.0B |
| IPO Year | 1998 | 2018 |
| Metric | KFY | TWST |
|---|---|---|
| Price | $62.66 | $46.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $78.00 | $48.75 |
| AVG Volume (30 Days) | 482.9K | ★ 1.4M |
| Earning Date | 03-11-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.09% | N/A |
| EPS Growth | 42.41 | ★ 63.89 |
| EPS | ★ 2.61 | N/A |
| Revenue | ★ $1,819,519,000.00 | $376,572,000.00 |
| Revenue This Year | $5.75 | $18.89 |
| Revenue Next Year | $4.02 | $15.28 |
| P/E Ratio | $23.90 | ★ N/A |
| Revenue Growth | 12.20 | ★ 20.32 |
| 52 Week Low | $58.95 | $23.30 |
| 52 Week High | $78.50 | $57.88 |
| Indicator | KFY | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 46.01 | 50.69 |
| Support Level | $62.46 | $25.67 |
| Resistance Level | $63.51 | $57.88 |
| Average True Range (ATR) | 2.11 | 3.10 |
| MACD | 0.13 | -0.90 |
| Stochastic Oscillator | 39.64 | 26.12 |
Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.